On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
Author:
Affiliation:
1. Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
2. Merck & Co., Inc., Kenilworth, NJ
3. MSD Belgium, Brussels, Belgium
Publisher
Oxford University Press (OUP)
Subject
Physiology (medical),Clinical Neurology
Link
http://academic.oup.com/sleep/article-pdf/38/11/1803/26671241/aasm.38.11.1803.pdf
Reference42 articles.
1. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence;Dassanayake;Drug Saf,2011
2. The relationship between benzodiazepine use and traffic accidents: a systematic literature review;Smink;CNS Drugs,2010
3. Residual effects of hypnotics: epidemiology and clinical implications;Vermeeren;CNS Drugs,2004
4. BELSOMRA (suvorexant) prescribing information;Merck & Co. Inc,2014
5. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist;Winrow;J Neurogenet,2011
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of an OX2R agonist on migration and removal of tau from mouse brain;Scientific Reports;2024-07-10
2. On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding;Medicine in Drug Discovery;2024-06
3. Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment;Neuropsychopharmacology Reports;2024-04-16
4. Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials;European Neuropsychopharmacology;2024-04
5. Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia;Pharmacology Research & Perspectives;2024-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3